Addus HomeCare (NASDAQ:ADUS) Lifted to “Strong-Buy” at StockNews.com

StockNews.com upgraded shares of Addus HomeCare (NASDAQ:ADUS) from a buy rating to a strong-buy rating in a report issued on Monday morning.

Other research analysts have also issued research reports about the stock. Stephens restated an overweight rating and issued a $115.00 price target on shares of Addus HomeCare in a report on Tuesday, May 7th. Oppenheimer reaffirmed an outperform rating and set a $118.00 price target on shares of Addus HomeCare in a research report on Tuesday, March 26th. TD Cowen raised their price objective on Addus HomeCare from $105.00 to $119.00 and gave the company a buy rating in a research report on Thursday, May 9th. William Blair reaffirmed an outperform rating on shares of Addus HomeCare in a research report on Monday, February 5th. Finally, Royal Bank of Canada reiterated an outperform rating and issued a $102.00 target price on shares of Addus HomeCare in a research note on Thursday, February 29th. One research analyst has rated the stock with a sell rating, seven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Addus HomeCare currently has a consensus rating of Moderate Buy and a consensus target price of $108.57.

Addus HomeCare Trading Down 0.4 %

Shares of ADUS stock opened at $110.27 on Monday. The company has a market capitalization of $1.81 billion, a price-to-earnings ratio of 27.36, a PEG ratio of 2.10 and a beta of 0.96. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.14. The firm has a 50-day moving average price of $101.46 and a 200 day moving average price of $94.70. Addus HomeCare has a twelve month low of $78.35 and a twelve month high of $111.99.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, May 6th. The company reported $1.21 EPS for the quarter, beating analysts’ consensus estimates of $0.97 by $0.24. Addus HomeCare had a return on equity of 10.03% and a net margin of 6.04%. The business had revenue of $280.70 million during the quarter, compared to the consensus estimate of $279.49 million. During the same quarter in the previous year, the business earned $0.84 earnings per share. The business’s revenue for the quarter was up 11.6% on a year-over-year basis. Research analysts forecast that Addus HomeCare will post 4.4 earnings per share for the current fiscal year.

Institutional Trading of Addus HomeCare

A number of hedge funds have recently made changes to their positions in ADUS. Principal Securities Inc. acquired a new stake in Addus HomeCare during the fourth quarter valued at approximately $26,000. GAMMA Investing LLC acquired a new stake in shares of Addus HomeCare during the 4th quarter valued at approximately $34,000. EntryPoint Capital LLC bought a new position in Addus HomeCare during the first quarter worth $44,000. Assetmark Inc. boosted its holdings in Addus HomeCare by 33.3% in the fourth quarter. Assetmark Inc. now owns 1,774 shares of the company’s stock worth $165,000 after purchasing an additional 443 shares during the period. Finally, DekaBank Deutsche Girozentrale acquired a new position in Addus HomeCare in the third quarter worth $189,000. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.